MALLIARAS, P., BARTON, C.J., REEVES, N.D
What is the relationship between BPC-157 and VEGFR2/FAK signaling pathways
While both peptides share the goal of enhancing recovery, their mechanisms of action, benefits, and applications differ in meaningful ways
In general, GHK-Cu has demonstrated good tolerability in research settings, particularly in topical applications
such as tendons, ligaments, brain, bone, etc Effective treatment for Traumatic brain injury (TBI) Protects and heals Inflamed Intestinal Epithelium (Leaky Gut Syndrome) Conditions BPC 157 has Improved or Helped with: Lymes disease Chronic viral or intracellular infections Chronic Fatigue Syndrome /Fibromyalgia Autoimmune Disease Inflammatory conditions Cardiovascular Disease Post-surgical repair Muscle Strains Ligament Sprains References: Some of the information shared in this post was referenced from our manufacturer Tavo Health